Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies (Details Narrative)

v3.25.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
$ in Millions
12 Months Ended
May 15, 2023
Dec. 31, 2024
Dec. 31, 2023
Reverse stock split 1-for-10 basis    
Antidilutive shares   3,000 5,000
Research And Development Expenses [Member]      
Prepaid expenses and other   $ 0.3 $ 0.5
Accrued expenses   $ 0.2 $ 0.1